Wednesday, May 17 2023
08:50 AM – 09:15 AM PT
Making Effective Gene Therapies Available For Patients With Rare Diseases
Claire Booth. UCL GOS Institute of Child Health, London, United Kingdom
Disclosures: C. Booth: 1; Commercial Interest i.e. Company X; Novartis. 1; What was received? i.e. Honorarium; Honorarium. 1; For what role? i.e. Speaker; Consulting. 2; Commercial Interest i.e. Company X; Chiesi. 2; What was received? i.e. Honorarium; Honorarium. 2; For what role? i.e. Speaker; Speaker/educational resources.